SCHEMBL25612469

SCHEMBL25612469

COC(=O)c1cc(C)cc(N)c1Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.47
ALDH1A1 P00352 6/20 0.46
GAA P10253 6/20 0.46
MAPT P10636 4/20 0.46
HSD17B10 Q99714 3/20 0.46
HPGD P15428 3/20 0.46
GLA P06280 2/20 0.46
CASP1 P29466 1/20 0.46
CASP7 P55210 1/20 0.46
ATM Q13315 1/20 0.46
CFTR P13569 3/20 0.46
ABL1 P00519 1/20 0.45
TSHR P16473 2/20 0.44
ALOX15 P16050 1/20 0.44
POLB P06746 2/20 0.40
XDH P47989 1/20 0.40
CYP46A1 Q9Y6A2 1/20 0.40
NPC1 O15118 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6119419 0.87 XDH (0.45) KDM4EALDH1A1GAAMAPTHSD17B10
SCHEMBL505337 0.81 KDM4E (0.50) KDM4EALDH1A1GAAMAPTHSD17B10
SCHEMBL6824936 0.81 KDM4E (0.50) KDM4EALDH1A1GAAMAPTHSD17B10
SCHEMBL28601825 0.81 XDH (0.41) KDM4EALDH1A1GAAMAPTPOLB
SCHEMBL13280615 0.81 ABL1 (0.60) KDM4EALDH1A1GAAMAPTHSD17B10
SCHEMBL15067775 0.81 KDM4E (0.46) KDM4EALDH1A1GAAMAPTHSD17B10
SCHEMBL6119252 0.80 SOS1 (0.42) KDM4EGAAMAPTHSD17B10TSHR
SCHEMBL11071838 0.80 KDM4E (0.49) KDM4EALDH1A1GAAMAPTHSD17B10
SCHEMBL27849858 0.79 KDM4E (0.55) KDM4EALDH1A1GAAMAPTGLA
SCHEMBL6118855 0.79 KDM4E (0.55) KDM4EALDH1A1GAAMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159421-A1 SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF Kynan Duke IP, LLC (US) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159421-A1 SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF CYP8B1, HSD11B1, HSD11B2 KDM4E 3324/4885ALDH1A1 288/4885GAA 1585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.